What is the Krebs Cycle? A Deep Dive into Cellular Respiration

The Krebs cycle, also known as the citric acid cycle or tricarboxylic acid (TCA) cycle, is a series of chemical reactions central to aerobic cellular respiration. It’s a metabolic pathway that extracts energy from molecules, releasing carbon dioxide and producing high-energy electron carriers. Understanding the Krebs cycle is fundamental to grasping how cells generate energy. This complex process occurs in the mitochondria of eukaryotic cells and the cytoplasm of prokaryotic cells.

Understanding the Krebs Cycle: A Step-by-Step Explanation

The Krebs cycle is a closed-loop series of eight enzymatic reactions that extract energy from acetyl-CoA, a molecule derived from carbohydrates, fats, and proteins. This cycle is a crucial link between glycolysis, the breakdown of glucose, and the electron transport chain, where most ATP (adenosine triphosphate), the cell’s primary energy currency, is produced.

Here’s a breakdown of each step:

1. Citrate Synthesis: Acetyl-CoA (2 carbons) combines with oxaloacetate (4 carbons) to form citrate (6 carbons), catalyzed by citrate synthase. This is often considered the first step and is highly exergonic, making it irreversible.

2. Isomerization of Citrate: Citrate is converted to its isomer, isocitrate, by the enzyme aconitase. This reaction involves the removal of water, followed by the addition of water back to the molecule.

3. Oxidative Decarboxylation of Isocitrate: Isocitrate dehydrogenase catalyzes the conversion of isocitrate to alpha-ketoglutarate. This step releases a molecule of carbon dioxide and produces NADH from NAD+.

4. Oxidative Decarboxylation of Alpha-Ketoglutarate: Alpha-ketoglutarate dehydrogenase complex converts alpha-ketoglutarate to succinyl-CoA. This step also releases carbon dioxide and produces another molecule of NADH. This complex is structurally and functionally similar to the pyruvate dehydrogenase complex.

5. Cleavage of Succinyl-CoA: Succinyl-CoA synthetase catalyzes the conversion of succinyl-CoA to succinate. This reaction is coupled with the phosphorylation of GDP to GTP (guanosine triphosphate), which can then be converted to ATP. This is an example of substrate-level phosphorylation.

6. Oxidation of Succinate: Succinate dehydrogenase oxidizes succinate to fumarate, producing FADH2 from FAD. This enzyme is unique because it’s embedded in the inner mitochondrial membrane and is also part of the electron transport chain (Complex II).

7. Hydration of Fumarate: Fumarate hydratase (also known as fumarase) catalyzes the hydration of fumarate to malate.

8. Oxidation of Malate: Malate dehydrogenase oxidizes malate to oxaloacetate, regenerating the initial four-carbon molecule needed to continue the cycle. This step also produces NADH.

The Importance of the Krebs Cycle

The Krebs cycle is vital for several reasons:

• Energy Production: It generates high-energy electron carriers (NADH and FADH2) that are essential for the electron transport chain, where the bulk of ATP is produced during aerobic respiration. For each molecule of acetyl-CoA that enters the cycle, 3 NADH, 1 FADH2, and 1 GTP (which is converted to ATP) are produced.
• Precursor Molecules: The cycle provides intermediate compounds used in the synthesis of amino acids, heme (a component of hemoglobin), and other essential molecules. These intermediates can be drawn off for various anabolic pathways (cataplerotic processes).
• Metabolic Hub: The Krebs cycle serves as a central hub, integrating carbohydrate, fat, and protein metabolism. Molecules from different sources can be funneled into the cycle to be oxidized for energy.

Regulation of the Krebs Cycle

The Krebs cycle is tightly regulated to meet the cell’s energy demands. Key regulatory points include:

• Citrate Synthase: Inhibited by ATP, NADH, and citrate.
• Isocitrate Dehydrogenase: Activated by ADP and calcium ions; inhibited by ATP and NADH.
• Alpha-Ketoglutarate Dehydrogenase: Inhibited by succinyl-CoA, NADH, and ATP.

The availability of substrates like acetyl-CoA and oxaloacetate also affects the cycle’s rate.

Clinical Significance: When the Krebs Cycle Goes Wrong

Defects in Krebs cycle enzymes can lead to various health problems. For example:

• Pyruvate Dehydrogenase Complex (PDC) Deficiency: Affects the conversion of pyruvate to acetyl-CoA, leading to lactic acidosis and neurological problems.
• Leigh Syndrome: A severe neurological disorder caused by mutations in genes encoding proteins of the PDC and other mitochondrial enzymes.
• Fumarase Deficiency: A rare autosomal recessive disorder that leads to severe developmental delay and neurological abnormalities.
• Isocitrate Dehydrogenase (IDH) Mutations: Found in some cancers, such as gliomas and leukemia. Mutant IDH enzymes produce 2-hydroxyglutarate, an oncometabolite that can promote tumor development.
• Thiamine Deficiency: Impacts the activity of the PDC and alpha-ketoglutarate dehydrogenase, leading to impaired energy production.

Understanding these clinical implications underscores the importance of the Krebs cycle for human health.

Anaplerotic and Cataplerotic Reactions

The Krebs cycle is not just a closed loop; it interacts with other metabolic pathways. Anaplerotic reactions replenish the cycle’s intermediates, while cataplerotic reactions remove them for biosynthesis.

• Anaplerotic Reactions: These reactions ensure that the cycle doesn’t run out of key components. Pyruvate carboxylase, for example, converts pyruvate to oxaloacetate, replenishing the cycle.
• Cataplerotic Reactions: These reactions draw intermediates from the cycle for the synthesis of other molecules. For example, citrate can be used to synthesize fatty acids, and alpha-ketoglutarate can be used to synthesize amino acids.

These interactions highlight the interconnectedness of metabolic pathways within the cell.

The Krebs Cycle and Oxidative Stress

Dysfunction within the Krebs cycle can contribute to oxidative stress. Impaired enzyme activity can lead to an accumulation of intermediates, potentially increasing the production of reactive oxygen species (ROS). This can cause damage to cellular components and contribute to various diseases.

Conclusion

The Krebs cycle is a fundamental metabolic pathway essential for energy production and biosynthesis. It is a complex and tightly regulated process that plays a crucial role in cellular respiration. A thorough understanding of the Krebs cycle is vital for comprehending cellular metabolism and its implications for health and disease. By providing energy and precursor molecules, the Krebs cycle supports numerous cellular functions and contributes to overall homeostasis.

References

1. Cavalcanti JH, Esteves-Ferreira AA, Quinhones CG, Pereira-Lima IA, Nunes-Nesi A, Fernie AR, Araújo WL. Evolution and functional implications of the tricarboxylic acid cycle as revealed by phylogenetic analysis. Genome Biol Evol. 2014 Oct 01;6(10):2830-48.
2. Sousa JS, D’Imprima E, Vonck J. Mitochondrial Respiratory Chain Complexes. Subcell Biochem. 2018;87:167-227.
3. Spydevold S, Davis EJ, Bremer J. Replenishment and depletion of citric acid cycle intermediates in skeletal muscle. Indication of pyruvate carboxylation. Eur J Biochem. 1976 Dec;71(1):155-65.
4. Haddad A, Mohiuddin SS. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 1, 2023. Biochemistry, Citric Acid Cycle.
5. Wiegand G, Remington SJ. Citrate synthase: structure, control, and mechanism. Annu Rev Biophys Biophys Chem. 1986;15:97-117.
6. Pechter KB, Meyer FM, Serio AW, Stülke J, Sonenshein AL. Two roles for aconitase in the regulation of tricarboxylic acid branch gene expression in Bacillus subtilis. J Bacteriol. 2013 Apr;195(7):1525-37.
7. Al-Khallaf H. Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight. Cell Biosci. 2017;7:37.
8. Krebs HA, Johnson WA. Metabolism of ketonic acids in animal tissues. Biochem J. 1937 Apr;31(4):645-60.
9. Tretter L, Adam-Vizi V. Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. Philos Trans R Soc Lond B Biol Sci. 2005 Dec 29;360(1464):2335-45.
10. Phillips D, Aponte AM, French SA, Chess DJ, Balaban RS. Succinyl-CoA synthetase is a phosphate target for the activation of mitochondrial metabolism. Biochemistry. 2009 Aug 04;48(30):7140-9.
11. Rutter J, Winge DR, Schiffman JD. Succinate dehydrogenase – Assembly, regulation and role in human disease. Mitochondrion. 2010 Jun;10(4):393-401.
12. Yogev O, Yogev O, Singer E, Shaulian E, Goldberg M, Fox TD, Pines O. Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol. 2010 Mar 09;8(3):e1000328.
13. Minárik P, Tomásková N, Kollárová M, Antalík M. Malate dehydrogenases–structure and function. Gen Physiol Biophys. 2002 Sep;21(3):257-65.
14. Hertz L, Hertz E. Cataplerotic TCA cycle flux determined as glutamate-sustained oxygen consumption in primary cultures of astrocytes. Neurochem Int. 2003 Sep-Oct;43(4-5):355-61.
15. Gibala MJ, MacLean DA, Graham TE, Saltin B. Anaplerotic processes in human skeletal muscle during brief dynamic exercise. J Physiol. 1997 Aug 01;502 ( Pt 3)(Pt 3):703-13.
16. Gupta N, Rutledge C. Pyruvate Dehydrogenase Complex Deficiency: An Unusual Cause of Recurrent Lactic Acidosis in a Paediatric Critical Care Unit. J Crit Care Med (Targu Mures). 2019 Apr;5(2):71-75.
17. Patel KP, O’Brien TW, Subramony SH, Shuster J, Stacpoole PW. The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol Genet Metab. 2012 Jul;106(3):385-94.
18. Brown GK, Otero LJ, LeGris M, Brown RM. Pyruvate dehydrogenase deficiency. J Med Genet. 1994 Nov;31(11):875-9.
19. Rahman S, Thorburn D. Nuclear Gene-Encoded Leigh Syndrome Spectrum Overview. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. University of Washington, Seattle; Seattle (WA): Oct 1, 2015.
20. Ball M, Thorburn DR, Rahman S. Mitochondrial DNA-Associated Leigh Syndrome Spectrum. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. University of Washington, Seattle; Seattle (WA): Oct 30, 2003.
21. Ruhoy IS, Saneto RP. The genetics of Leigh syndrome and its implications for clinical practice and risk management. Appl Clin Genet. 2014;7:221-34.
22. Dhir S, Tarasenko M, Napoli E, Giulivi C. Neurological, Psychiatric, and Biochemical Aspects of Thiamine Deficiency in Children and Adults. Front Psychiatry. 2019;10:207.
23. Wiley KD, Gupta M. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 17, 2023. Vitamin B1 (Thiamine) Deficiency.
24. Ryder B, Moore F, Mitchell A, Thompson S, Christodoulou J, Balasubramaniam S. Fumarase Deficiency: A Safe and Potentially Disease Modifying Effect of High Fat/Low Carbohydrate Diet. JIMD Rep. 2018;40:77-83.
25. Coman D, Kranc KR, Christodoulou J. Fumarate Hydratase Deficiency. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. University of Washington, Seattle; Seattle (WA): Jul 5, 2006.
26. Gellera C, Uziel G, Rimoldi M, Zeviani M, Laverda A, Carrara F, DiDonato S. Fumarase deficiency is an autosomal recessive encephalopathy affecting both the mitochondrial and the cytosolic enzymes. Neurology. 1990 Mar;40(3 Pt 1):495-9.
27. Ezgu F, Krejci P, Wilcox WR. Mild clinical presentation and prolonged survival of a patient with fumarase deficiency due to the combination of a known and a novel mutation in FH gene. Gene. 2013 Jul 25;524(2):403-6.
28. Wu F, Cheng G, Yao Y, Kogiso M, Jiang H, Li XN, Song Y. Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer. Med Chem. 2018;14(7):715-724.
29. Reitman ZJ, Yan H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism. J Natl Cancer Inst. 2010 Jul 07;102(13):932-41.
30. Guo C, Pirozzi CJ, Lopez GY, Yan H. Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target. Curr Opin Neurol. 2011 Dec;24(6):648-52.